Click here to BLOCK YOUR CONTENT SPACE IN OUR NEXT ISSUES
|
|
|
Industry Insights |
|
|
Rising Demand Fuels Asia Pacific Pharmaceutical CDMO Market
The APAC Pharmaceutical CDMO market is to reach US$140.03B by 2031, driven by the cost advantages, skilled workforce, and improved infrastructure of the region.
|
|
|
|
|
|
|
|
|
|
R&D innovation advancing small molecule innovator CDMO market
The rising demand, higher R&D costs, and outsourcing trends in the pharmaceutical industry are fueling the growth of the small molecule innovator CDMO market.
|
|
|
|
|
|
Cell And Gene Therapy CDMO Services Market Is On The Rise
Expanding therapy pipeline, increased investments, and other factors will drive the global cell and gene therapy CDMO services market growth during 2023-2029
|
|
|
|
|
|
|
|
|
|
Lack of Experience Hinders CDMOs In Cell And Gene Therapy
The pharma sterility testing market is set to grow to $1.0223B by 2032, driven by quality emphasis, government investments, and the introduction of new drugs.
|
|
|
|
|
|
Rapid Expansion Projected In Pharma Sterility Testing Market
The pharma sterility testing market is set to grow to $1.0223B by 2032, driven by quality emphasis, government investments, and the introduction of new drugs.
|
|
|
|
|
|
|
|
|
|
Pharma Dealmaking Recovery Gets Boosted By $85bn M&A Splurge
Action by the FTC in certain cases has gone on to raise a megadeal risk, thereby reflecting poorly upon the drugmakers appetite for increased takeovers lately.
|
|
|
|
|
|